Skip to content

The effect of curcumin in the prevention of kidney failure following heart angiography

The effect of curcumin in the prevention of contrast induced nephropathy in patients with moderate kidney failure following coronary angioplasty or angiography

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT138706261256N1
Enrollment
60
Registered
2017-10-24
Start date
2016-10-11
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute kidney injury. Renal Failure

Interventions

Intervention 1: Control group receive placebo capsule 500 mg three times daily from 2 days before angiography until 3 days after it. Intervention 2: Intervention group receive Curcumin capsule 500 mg
Treatment - Drugs
Control group receive placebo capsule 500 mg three times daily from 2 days before angiography until 3 days after it.
Intervention group receive Curcumin capsule 500 mg three times daily from 2 days before angiography until 3 days after it.

Sponsors

Vice Chancellor Of Research, Mashad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria: All patients undergoing elective coronary angiography who are older than 18 years and are suffering from chronic kidney failure. Exclusion criteria: patients on dialysis, acute renal failure before angiography, cardiogenic shock, heart failure, use of medications such as N-acetyl cysteine, vitamin C, use of intravenous contrast to other causes, mannitol, diuretics, theophylline, warfarin and dopamine in the past two weeks.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Serum creatinine. Timepoint: 0,1,3 days- 1th day. Method of measurement: mg/dl.;Urinary NGAL. Timepoint: First day. Method of measurement: ng/ml.

Secondary

MeasureTime frame
Nausea. Timepoint: daily. Method of measurement: history &physical exam.;Diarrhea. Timepoint: daily. Method of measurement: history &physical exam.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohsen Tafaghodi

Vice Chancellor Of Research, Mashad University of Medical Sciences

tafaghodim@mums.ac.ir+98 51 3841 1538

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026